Silver nanoparticles as a smart antimicrobial agent

Journal of Bacteriology and Virology

Volumn 42, Issue 2, 2012, Pages 177-179

  Yang, Eun Jeong ^a   Jang, Jiyoung ^a   Kim, Seungjae ^a   Choi, In Hong ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Antimicrobial agent; Silver nanoparticles

Indexed keywords

EID: 84922685821     PISSN: 15982467     EISSN: None     Source Type: Journal    
DOI: 10.4167/jbv.2012.42.2.177     Document Type: Letter

References (25)

1. Mainous AG, Diaz VA, Matheson EM, Gregorie SH, Hueston WJ. Trends in hospitalizations with antibiotic-resistant infections: U.S., 1997-2006. Public Health Rep 2011;126:354-360.
2. Westh H, Zinn CS, Rosdahl VT. An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries. Microb Drug Resist 2004; 10:169-176.
3. Alexander JW. History of the medical use of asilver. Surg Infect (Larchmt) 2009;10:289-292.
4. Amato E, Diaz-Fernandez YA, Taglietti A, Pallavicini P, Pasotti L, Cucca L, et al. Synthesis, characterization and antibacterial activity against Gram positive and Gram negative bacteria of biomimetically coated silver nanoparticles. Langmuir 2011;27:9165-9173.
5. Brandt O, Mildner M, Egger AE, Groessl M, Rix U, Posch M, et al. Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine. Nanomedicine 2012;8:478-488.
6. Guzman M, Dille J, Godet S. Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomedicine 2012;8:37-45.
7. Kim SW, Baek YW, An YJ. Assay-dependent effect of silver nanoparticles to Escherichia coli and Bacillus subtilis. Appl Microbiol Biotechnol 2011;92:1045-1052.
8. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007;3:95-101.
9. Sintubin L, De Gusseme B, Van der Meeren P, Pycke BF, Verstraete W, Boon N. The antibacterial activity of biogenic silver and its mode of action. Appl Microbiol Biotechnol 2011;91:153-162.
10. Sharma VK, Yngard RA, Lin Y. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interface Sci 2009;145:83-96.
11. Park J, Lim DH, Lim HJ, Kwon T, Choi JS, Jeong S, et al. Size dependent macrophage responses and toxico-logical effects of Ag nanoparticles. Chem Commun (Camb) 2011;47:4382-4384.
12. Li WR, Xie XB, Shi QS, Duan SS, Ouyang YS, Chen YB. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Biometals 2011;24:135-141.
13. Hermans MH. Silver-containing dressings and the need for evidence. Adv Skin Wound Care 2007;20:166-173; quiz 74-5.
14. Toy LW, Macera L. Evidence-based review of silver dressing use on chronic wounds. J Am Acad Nurse Pract 2011;23:183-192.
15. Percival SL, Thomas J, Linton S, Okel T, Corum L, Slone W. The antimicrobial efficacy of silver on antibiotic-resistant bacteria isolated from burn wounds. Int Wound J 2011.
16. Guthrie KM, Agarwal A, Tackes DS, Johnson KW, Abbott NL, Murphy CJ, et al. Antibacterial efficacy of silver-Impregnated polyelectrolyte multilayers immobilized on a biological dressing in a murine Wound Infection Model. Ann Surg 2012.
17. Li D, Diao J, Zhang J, Liu J. Fabrication of new chitosan-based composite sponge containing silver nanoparticles and its antibacterial properties for wound dressing. J Nanosci Nanotechnol 2011;11:4733-4738.
18. Marie Arockianathan P, Sekar S, Kumaran B, Sastry TP. Preparation, characterization and evaluation of bio-composite films containing chitosan and sago starch impregnated with silver nanoparticles. Int J Biol Macromol 2012;50:939-946.
19. Kang K, Lim DH, Choi IH, Kang T, Lee K, Moon EY, et al. Vascular tube formation and angiogenesis induced by polyvinylpyrrolidone-coated silver nanoparticles. Toxicol Lett 2011;205:227-234.
20. Chen M, Yang Z, Wu H, Pan X, Xie X, Wu C. Antimicrobial activity and the mechanism of silver nanoparticle thermosensitive gel. Int J Nanomedicine 2011;6:2873-2877.
21. Ebert M, Assadian O, Hubner NO, Koburger T, Kramer A. Antimicrobial efficacy of the silver wound dressing Biatain Ag in a disc carrier test simulating wound secretion. Skin Pharmacol Physiol 2011;24:337-341.
22. Lara HH, Ixtepan-Turrent L, Garza Trevino EN, Singh DK. Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins. J Nanobiotechnology 2011;9:38.
23. Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk JM, et al. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther 2008;13:253-262.
24. Xiang DX, Chen Q, Pang L, Zheng CL. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Virol Methods 2011;178:137-142.
25. Speshock JL, Murdock RC, Braydich-Stolle LK, Schrand AM, Hussain SM. Interaction of silver nano-particles with Tacaribe virus. J Nanobiotechnology 2010;8:19.